Metabolism and excretion of asoprisnil, a novel selective progesterone receptor modulator, in healthy female subjects

被引：0
|
作者：
Lee, Ronald
Grabowski, Brian
Mulford, Darcy
Castagnoli, Neal
Rottmann, Antje
Chwalisz, Kristof
机构：
[1] TAP Pharmaceut Prod Inc, DMPK, Lake Forest, IL USA
[2] Virginia Polytech Inst & State Univ, Dept Chem, Blacksburg, VA 24061 USA
[3] Schering AG, Pharmacokinet Metab & Bioanalysis, D-1000 Berlin, Germany
[4] TAP Pharmaceut Prod Inc, Womens Hlth, Lake Forest, IL USA
来源：
DRUG METABOLISM REVIEWS | 2006年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
268
引用
收藏
页码：172 / 173
页数：2
相关论文
共 50 条
  • [1] Effect of asoprisnil, a novel selective progesterone receptor modulator, on the QT interval in healthy female subjects
    Lee, RD
    Edmonds, A
    Chwalisz, K
    Vernillet, L
    JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (09): : 1083 - 1083
  • [2] Effects of the novel selective progesterone receptor modulator (SPRM) asoprisnil on bleeding patterns in subjects with leiomyomata.
    Chwalisz, K
    Larsen, L
    McCrary, K
    Edmonds, A
    JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2004, 11 (02) : 320A - 321A
  • [3] Asoprisnil, a novel selective progesterone receptor modulator (SPRM), controls abnormal uterine bleeding in subjects with leiomyomata
    Chwalisz, K
    Larsen, L
    Mattia-Goldberg, C
    McCrary, K
    Edmonds, A
    Human Reproduction, 2005, : 556 - 556
  • [4] Treatment of endometriosis with the novel selective progesterone receptor modulator (SPRM) asoprisnil.
    Chwalisz, K
    Mattia-Goldberg, C
    Lee, M
    Elger, W
    Edmonds, A
    FERTILITY AND STERILITY, 2004, 82 : S83 - S84
  • [5] Effects of the novel selective progesterone receptor modulator (SPRM) asoprisnil on selected hormonal parameters in subjects with leiomyomata.
    Chwalisz, K
    Larsen, L
    McCrary, K
    Edmonds, A
    FERTILITY AND STERILITY, 2004, 82 : S306 - S306
  • [6] A structural and in vitro characterization of asoprisnil:: A selective progesterone receptor modulator
    Madauss, Kevin P.
    Grygielko, Eugene T.
    Deng, Su-Jun
    Sulpizio, Anthony C.
    Stanley, Thomas B.
    Wu, Charlene
    Short, Steve A.
    Thompson, Scott K.
    Stewart, Eugene L.
    Laping, Nicholas J.
    Williams, Shawn P.
    Bray, Jeffrey D.
    MOLECULAR ENDOCRINOLOGY, 2007, 21 (05) : 1066 - 1081
  • [7] Therapeutic potential for the selective progesterone receptor modulator asoprisnil in the treatment of leiomyomata
    Chwalisz, K
    DeManno, D
    Garg, R
    Larsen, L
    Mattia-Goldberg, C
    Stickler, T
    SEMINARS IN REPRODUCTIVE MEDICINE, 2004, 22 (02) : 113 - 119
  • [8] A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata
    Chwalisz, Kristof
    Larsen, Lois
    Mattia-Goldberg, Cynthia
    Edmonds, Anthony
    Elger, Walter
    Winkel, Craig A.
    FERTILITY AND STERILITY, 2007, 87 (06) : 1399 - 1412
  • [9] Asoprisnil -: Endometriosis therapy treatment of uterine fibroids selective progesterone receptor modulator
    Cole, P
    Castañer, J
    Fernández-Forner, D
    DRUGS OF THE FUTURE, 2005, 30 (10) : 985 - 991
  • [10] Asoprisnil (J867): a selective progesterone receptor modulator for gynecological therapy
    DeManno, D
    Elger, W
    Garg, R
    Lee, R
    Schneider, B
    Hess-Stumpp, H
    Schubert, G
    Chwalisz, K
    STEROIDS, 2003, 68 (10-13) : 1019 - 1032
12345